new medicines

Market Access

EMA’s strategy for speeding up drug approvals in the EU

The EMA is implementing major changes to accelerate drug approvals in the EU, addressing delays that affect patients and businesses alike

Digital

accelerating delivery of new medicines to patients

Power of digital technology and partnership to accelerate de...

We are living through the fastest period of digital growth in human history. New technologies are transforming how we live, work, connect and innovate.

Sales & Marketing

Balancing interests in launching medicines

Launching new medicine at the right price is a complex issue, requiring a balance of interests

Market Access

Innovative Medicines Fund and the opportunity for ICSs-indus...

In June 2022, NHS England (NHSE) and the National Institute for Health and Care Excellence (NICE) launched the Innovative Medicines Fund (IMF).

EMA’s strategy for speeding up drug approvals in the EU

Power of digital technology and partnership to accelerate de...

Balancing interests in launching medicines

Innovative Medicines Fund and the opportunity for ICSs-indus...

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

new medicines

Editor's Picks